Shanghai MicroPort Endovascular MedTech (688016) Stock Overview
Shanghai MicroPort Endovascular MedTech Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
688016 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Shanghai MicroPort Endovascular MedTech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥97.40 |
| 52 Week High | CN¥124.30 |
| 52 Week Low | CN¥81.81 |
| Beta | 0.31 |
| 1 Month Change | -4.27% |
| 3 Month Change | -19.02% |
| 1 Year Change | -6.87% |
| 3 Year Change | -24.30% |
| 5 Year Change | -35.98% |
| Change since IPO | -8.32% |
Recent News & Updates
Recent updates
A Look At The Fair Value Of Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016)
Mar 24
Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Shares Lagging The Market But So Is The Business
Jan 03Investors Met With Slowing Returns on Capital At Shanghai MicroPort Endovascular MedTech (SHSE:688016)
Dec 16Calculating The Fair Value Of Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016)
Nov 27Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Attractive Earnings Are Not All Good News For Shareholders
Nov 06There's No Escaping Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Muted Earnings Despite A 31% Share Price Rise
Oct 01Earnings Miss: Shanghai MicroPort Endovascular MedTech Co., Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts
Aug 29Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends
Aug 15Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel
Jun 29These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely
Apr 29Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem
Apr 09Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't
Mar 25Shareholder Returns
| 688016 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -3.5% | -1.8% | -1.1% |
| 1Y | -6.9% | 0.9% | 23.0% |
Return vs Industry: 688016 underperformed the CN Medical Equipment industry which returned 0.9% over the past year.
Return vs Market: 688016 underperformed the CN Market which returned 23% over the past year.
Price Volatility
| 688016 volatility | |
|---|---|
| 688016 Average Weekly Movement | 4.5% |
| Medical Equipment Industry Average Movement | 4.8% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 9.4% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 688016 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688016's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 832 | Qing Zhu | www.endovastec.com |
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company’s products include branched aortic stent graft system, thoracic stent graft system, abdominal aortic stent graft and delivery system, bifurcated stent graft system, and other stent graft system in surgical operation, as well as accessories, such as balloon inflation catheter.
Shanghai MicroPort Endovascular MedTech Co., Ltd. Fundamentals Summary
| 688016 fundamental statistics | |
|---|---|
| Market cap | CN¥11.78b |
| Earnings (TTM) | CN¥377.82m |
| Revenue (TTM) | CN¥1.25b |
Is 688016 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688016 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.25b |
| Cost of Revenue | CN¥393.06m |
| Gross Profit | CN¥858.48m |
| Other Expenses | CN¥480.66m |
| Earnings | CN¥377.82m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.12 |
| Gross Margin | 68.59% |
| Net Profit Margin | 30.19% |
| Debt/Equity Ratio | 0% |
How did 688016 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/18 17:56 |
| End of Day Share Price | 2025/11/18 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai MicroPort Endovascular MedTech Co., Ltd. is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Yuan Gao | China International Capital Corporation Limited |
| Bo Yu | China International Capital Corporation Limited |